|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Favoriti P, Carbone G, Greco M, Pirozzi F,
Pirozzi RE and Corcione F: Worldwide burden of colorectal cancer: A
review. Updates Surg. 68:7–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Singh D, Srivastava SK, Chaudhuri TK and
Upadhyay G: Multifaceted role of matrix metalloproteinases (MMPs).
Front Mol Biosci. 2:192015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gialeli C, Theocharis AD and Karamanos NK:
Roles of matrix metalloproteinases in cancer progression and their
pharmacological targeting. FEBS J. 278:16–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Page-McCaw A, Ewald AJ and Werb Z: Matrix
metalloproteinases and the regulation of tissue remodelling. Nat
Rev Mol Cell Biol. 8:221–233. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
McCawley LJ and Matrisian LM: Matrix
metalloproteinases: They're not just for matrix anymore. Curr Opin
Cell Biol. 13:534–540. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shintani T, Kusuhara Y, Daizumoto K,
Dondoo TO, Yamamoto H, Mori H, Fukawa T, Nakatsuji H, Fukumori T,
Takahashi M and Kanayama H: The involvement of hepatocyte growth
Factor-MET-Matrix metalloproteinase 1 signaling in bladder cancer
invasiveness and proliferation. Effect of the MET inhibitor,
Cabozantinib (XL184), on bladder cancer cells. Urology.
101:169.e7–169.e13. 2017. View Article : Google Scholar
|
|
10
|
Wang J, Liu D, Zhou W, Wang M, Xia W and
Tang Q: Prognostic value of matrix
metalloprotease-1/protease-activated receptor-1 axis in patients
with prostate cancer. Med Oncol. 31:9682014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim M, Kim HJ, Choi BY, Kim JH, Song KS,
Noh SM, Kim JC, Han DS, Kim SY and Kim YS: Identification of
potential serum biomarkers for gastric cancer by a novel
computational method, multiple normal tissues corrected
differential analysis. Clin Chim Acta. 413:428–433. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamamoto H, Itoh F, Iku S, Adachi Y,
Fukushima H, Sasaki S, Mukaiya M, Hirata K and Imai K: Expression
of matrix metalloproteinases and tissue inhibitors of
metalloproteinases in human pancreatic adenocarcinomas:
Clinicopathologic and prognostic significance of matrilysin
expression. J Clin Oncol. 19:1118–1127. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pittayapruek P, Meephansan J, Prapapan O,
Komine M and Ohtsuki M: Role of matrix metalloproteinases in
photoaging and photocarcinogenesis. Int J Mol Sci. 17(pii):
E8682016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saito R, Miki Y, Ishida N, Inoue C,
Kobayashi M, Hata S, Yamada-Okabe H, Okada Y and Sasano H: The
significance of MMP-1 in EGFR-TKI-resistant lung adenocarcinoma:
Potential for therapeutic targeting. Int J Mol Sci. 19(pii):
E6092018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bendardaf R, Buhmeida A, Ristamäki R,
Syrjänen K and Pyrhönen S: MMP-1 (collagenase-1) expression in
primary colorectal cancer and its metastases. Scand J
Gastroenterol. 42:1473–1478. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shiozawa J, Ito M, Nakayama T, Nakashima
M, Kohno S and Sekine I: Expression of matrix metalloproteinase-1
in human colorectal carcinoma. Mod Pathol. 13:925–933. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gurzu S, Silveanu C, Fetyko A, Butiurca V,
Kovacs Z and Jung I: Systematic review of the old and new concepts
in the epithelial-mesenchymal transition of colorectal cancer.
World J Gastroenterol. 22:6764–675. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Prieto-García E, Díaz-García CV,
García-Ruiz I and Agulló-Ortuño MT: Epithelial-to-mesenchymal
transition in tumor progression. Med Oncol. 34:1222017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sakamoto T, Kawano S, Matsubara R, Goto Y,
Jinno T, Maruse Y, Kaneko N, Hashiguchi Y, Hattori T, Tanaka S, et
al: Critical roles of Wnt5a-Ror2 signaling in aggressiveness of
tongue squamous cell carcinoma and production of matrix
metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal
transition. Oral Oncol. 69:15–25. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang Y, Jiao Y, Liu Y, Zhang M, Wang Z,
Li Y, Li T, Zhao X and Wang D: Sinomenine hydrochloride inhibits
the metastasis of human glioblastoma cells by suppressing the
expression of matrix Metalloproteinase-2/-9 and reversing the
endogenous and exogenous Epithelial-mesenchymal transition. Int J
Mol Sci. 9(pii): E8442018. View Article : Google Scholar
|
|
22
|
Lee H, Ko JH, Baek SH, Nam D, Lee SG, Lee
J, Yang WM, Um JY, Kim SH, Shim BS and Ahn KS: Embelin inhibits
invasion and migration of MDA-MB-231 breast cancer cells by
suppression of CXC chemokine receptor 4, matrix
Metalloproteinases-9/2, and Epithelial-mesenchymal transition.
Phytother Res. 30:1021–1032. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chatterjee K, Jana S, DasMahapatra P and
Swarnakar S: EGFR-mediated matrix metalloproteinase-7 up-regulation
promotes epithelial-mesenchymal transition via ERK1-AP1 axis during
ovarian endometriosis progression. FASEB J. 32:4560–4572. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong
XY, Gu Q, Yao Z and Sun BC: Promotion of hepatocellular carcinoma
metastasis through matrix metalloproteinase activation by
epithelial-mesenchymal transition regulator Twist1. J Cell Mol Med.
15:691–700. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen GH, Huang CH, Luo HY and Jiang ST:
Effect of small interfering RNAs on matrix metalloproteinase 1
expression. Biotechnol Rep (Amst). 4:5–13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu M, Hu Y, Zhang MF, Luo KJ, Xie XY, Wen
J, Fu JH and Yang H: MMP1 promotes tumor growth and metastasis in
esophageal squamous cell carcinoma. Cancer Lett. 377:97–104. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Langenskiöld M, Ivarsson ML, Holmdahl L,
Falk P, Kåbjörn-Gustafsson C and Angenete E: Intestinal mucosal
MMP-1-a prognostic factor in colon cancer. Scand J Gastroenterol.
48:563–569. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bianco BC, Scotti FM, Vieira DS, Biz MT,
Castro RG and Modolo F: Immunohistochemical expression of matrix
metalloproteinase-1, matrix metalloproteinase-2 and matrix
metalloproteinase-9, myofibroblasts and Ki-67 in actinic cheilitis
and lip squamous cell carcinoma. Int J Exp Pathol. 96:311–318.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang QM, Lv L, Tang Y, Zhang L and Wang
LF: MMP-1 is overexpressed in triple-negative breast cancer tissues
and the knockdown of MMP-1 expression inhibits tumor cell malignant
behaviors in vitro. Oncol Lett. 17:1732–1740.
2019.PubMed/NCBI
|
|
30
|
Eiró N, González LO, Atienza S,
González-Quintana JM, Beridze N, Fernandez-Garcia B,
Pérez-Fernández R, García-Caballero T, Schneider J and Vizoso FJ:
Prediction of metastatic breast cancer in non-sentinel lymph nodes
based on metalloprotease-1 expression by the sentinel lymph node.
Eur J Cancer. 49:1009–1017. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Grimm M, Lazariotou M, Kircher S, Stuermer
L, Reiber C, Höfelmayr A, Gattenlöhner S, Otto C, Germer CT and von
Rahden BH: MMP-1 is a (pre-)invasive factor in Barrett-associated
esophageal adenocarcinomas and is associated with positive lymph
node status. J Transl Med. 8:992010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Z, Pan J, Li L, Wang Z, Xiao W and
Li N: Survey of risk factors contributed to lymphatic metastasis in
patients with oral tongue cancer by immunohistochemistry. J Oral
Pathol Med. 40:127–134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lassig AAD, Joseph AM, Lindgren BR and
Yueh B: Association of oral cavity and oropharyngeal cancer
biomarkers in surgical drain fluid with patient outcomes. JAMA
Otolaryngol Head Neck Surg. 143:670–678. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weiss MB, Abel EV, Mayberry MM, Basile KJ,
Berger AC and Aplin AE: TWIST1 is an ERK1/2 effector that promotes
invasion and regulates MMP-1 expression in human melanoma cells.
Cancer Res. 72:6382–6392. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fuhrman-Luck RA, Stansfield SH, Stephens
CR, Loessner D and Clements JA: Prostate Cancer-associated
Kallikrein-related peptidase 4 activates matrix Metalloproteinase-1
and Thrombospondin-1. J Proteome Res. 15:2466–2478. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang C, Li Y, Guo Y, Zhang Z, Lian G,
Chen Y, Li J, Su Y, Li J, Yang K, et al: MMP1/PAR1/SP/NK1R
paracrine loop modulates early perineural invasion of pancreatic
cancer cells. Theranostics. 8:3074–3086. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Juncker-Jensen A, Deryugina EI, Rimann I,
Zajac E, Kupriyanova TA, Engelholm LH and Quigley JP: Tumor MMP-1
activates endothelial PAR1 to facilitate vascular intravasation and
metastatic dissemination. Cancer Res. 73:4196–4211. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dong F, Eibach M, Bartsch JW, Dolga AM,
Schlomann U, Conrad C, Schieber S, Schilling O, Biniossek ML,
Culmsee C, et al: The metalloprotease-disintegrin ADAM8 contributes
to temozolomide chemoresistance and enhanced invasiveness of human
glioblastoma cells. Neuro Oncol. 17:1474–1485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hanrahan K, O'Neill A, Prencipe M, Bugler
J, Murphy L, Fabre A, Puhr M, Culig Z, Murphy K and Watson RW: The
role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in
mediating Docetaxel-resistant prostate cancer. Mol Oncol.
11:251–265. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pal I, Rajesh Y, Banik P, Dey G, Dey KK,
Bharti R, Naskar D, Chakraborty S, Ghosh SK, Das SK, et al:
Prevention of epithelial to mesenchymal transition in colorectal
carcinoma by regulation of the E-cadherin-β-catenin-vinculin axis.
Cancer Lett. 452:254–263. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Derycke LD and Bracke ME: N-cadherin in
the spotlight of cell-cell adhesion, differentiation,
embryogenesis, invasion and signalling. Int J Dev Biol. 48:463–476.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Satelli A and Li S: Vimentin in cancer and
its potential as a molecular target for cancer therapy. Cell Mol
Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang D, Rai B, Qi F, Liu T, Wang J, Wang X
and Ma B: Influence of the Twist gene on the invasion and
metastasis of colon cancer. Oncol Rep. 39:31–44. 2018.PubMed/NCBI
|
